Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism

Endocrine Practice

Volumn 18, Issue 4, 2012, Pages 450-455

  Morris, G Stephen ^a   Landry, Christine L ^a   Grubbs, Elizabeth G ^a   Jimenez, Camilo ^a   Busaidy, Naifa L ^a   Perrier, Nancy D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; FATIGUE; FEMALE; FUNCTIONAL STATUS; GAIT; HUMAN; MALAISE; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL CAPACITY; PRIMARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL; WALKING SPEED; WEAKNESS;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; COHORT STUDIES; DEPRESSION; FATIGUE; FEMALE; GERIATRIC ASSESSMENT; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PARATHYROID GLANDS; PARATHYROID HORMONE; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 84864643514     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11206.OR     Document Type: Article

References (37)

1. Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist. 2007;12:644-653.
2. Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab. 1999;84:2275-2285.
3. Okamoto T, Kamo T, Obara T. Outcome study of psycho-logical distress and nonspecifc symptoms in patients with mild primary hyperparathyroidism. Arch Surg. 2002;137: 779-783.
4. Cholod EJ, Haust MD, Hudson AJ, Lewis FN. Myopathy in primary familial hyperparathyroidism: clinical and mor-phologic studies. Am J Med. 1970;48:700-707.
5. Visser M, Deeg DJ, Lips P (Longitudinal Aging Study Amsterdam). Low vitamin D and high parathyroid hor-mone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766-5772.
6. Reppe S, Stilgren L, Abrahamsen B, et al. Abnormal muscle and hematopoietic gene expression may be impor-tant for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab. 2007;292:E1465- E1473.
7. Roubenoff R, Hughes VA. Sarcopenia: current concepts. J Gerontol A Biol Sci Med Sci. 2000;55:M716-M724.
8. Visser M, Kritchevsky SB, Goodpaster BH, et al. Leg muscle mass and composition in relation to lower extrem-ity performance in men and women aged 70-79: the health, aging and body compostion study. J Am Geriatr Soc. 2002; 50:897-904.
9. Rantanen T, Guralnik JM, Sakari-Rantala R, et al. Disability, physical activity, and muscle strength in older women: the Women's Health and Aging Study. Arch Physiol Med Rehabil. 1999;80:130-135.
10. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci. 2002;57: B359-B365.
11. ATS Committee on Profciency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
12. Morris GS, Brueilly KE, Scheetz JS, Brennan EA. Functional performance status of hematopoietic SCT recipients in the sub-acute phase of recovery Bone Marrow Transplant. 2009;45:755-761.
13. Simmonds MJ. Physical function in patients with can-cer: psychometric characteristics and clinical usefulness of a physical performance test battery J Pain Symptom Manage. 2002;24:404-414.
14. Duncan PW, Weiner DK, Chandler J, Studenski S. Functional reach: a new clinical measure of balance. J Gerontol. 1990;45:M192-M197.
15. Rothstein JM, Echternach JL. Primer on Measurement: An Introductory Guide to Measurement Issues. Alexandria, VA: American Physical Therapy Association, 1993.
16. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14:270-274.
17. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance bat-tery. J Gerontol A Biol Sci Med Sci. 2000;55:M221-M231.
18. Bohannon RW. Population representative gait speed and its determinants. J Geriatr Phys Ther. 2008;31:49-52.
19. Obesity: preventing and managing the global epidemic; report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
20. Robinett CS, Vondran MA. Functional ambulation veloc-ity and distance requirements in rural and urban communi-ties: a clinical report. Phys Ther. 1988;68:1371-1372.
21. Myers AM, Holliday PJ, Harvey KA, Hutchinson KS. Functional performance measures: are they superior to self-assessments? J Gerontol. 1993;48:M196-M206.
22. Chuang ML, Lin IF, Wasserman K. The body weight-walking distance product as related to lung function, anaer-obic threshold and peak V O2 in COPD patients. Respir Med. 2001;95:618-626.
23. Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-Minute walk work for assess-ment of functional capacity in patients with COPD. Chest. 2003;123:1408-1415.
24. Duncan PW, Studenski S, Chandler J, Prescott B. Functional reach: predictive validity in a sample of elderly male veterans. J Gerontol. 1992;47:M93-M98.
25. Joborn C, Joborn H, Rastad J, Akerström G, Ljunghall S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery Br J Surg. 1988;75:77-80.
26. Kristoffersson A, Boström A, Söderberg T. Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg. 1992;79: 165-168.
27. Ureña P, Kong XF, Abou-Samra AB, et al. Parathyroid hormone (PTH)/PTH-related peptide receptor messen-ger ribonucleic acids are widely distributed in rat tissues. Endocrinology. 1993;133:617-623.
28. Ceglia L. Vitamin D and skeletal muscle tissue and func-tion. Mol Aspects Med 2008;29:407-414
29. Guralnik JM, Seeman TE, Tinetti ME, Nevitt MC, Berkman LF. Validation and use of performance mea-sures of functioning in a non-disabled older population: MacArthur studies of successful aging. Aging (Milano). 1994;6:410-419.
30. Tinetti ME, Mendes de Leon CF, Doucette JT, Baker DI. Fear of falling and fall-related effcacy in relationship to functioning among community-living elders. J Gerontol. 1994;49:M140-M147.
31. Fuller-Thomson E, Yu B, Nuru-Jeter A, Guralnik JM, Minkler M. Basic ADL disability and functional limita-tion rates among older Americans from 2000-2005: the end of the decline? J Gerontol A Biol Sci Med Sci. 2009;64: 1333-1336.
32. Abellan van Kan G, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B. The assessment of frailty in older adults. Clin Geriatr Med. 2010;26:275-286.
33. Motl RW, McAuley E. Physical activity, disability, and quality of life in older adults. Phys Med Rehabil Clin N Am. 2010;21:299-308.
34. Cooper R, Kuh D, Hardy R (Mortality Review Group; FALCon and HALCyon Study Teams). Objectively mea-sured physical capability levels and mortality: systematic review and meta-analysis published online ahead of print September 9, 2010. BMJ. 2010;341:c4467. doi: 10.1136/bmj.c4467.
35. Protas EJ, Tissier S. Strength and speed training for elders with mobility disability J Aging Phys Act. 2009;17:257-271.
36. Chalé-Rush A, Guralnik JM, Walkup MP, et al. Relationship between physical functioning and physical activity in the lifestyle interventions and independence for elders pilot. J Am Geriatr Soc. 2010;58:1918-1924.
37. Bonhannon RW. Body mass index and mobility of older home care patients. Physiother Theory Pract. 2011;27: 460-462.